{"id":1864,"date":"2024-03-26T14:36:01","date_gmt":"2024-03-26T14:36:01","guid":{"rendered":"https:\/\/stoxpo.com\/?p=1864"},"modified":"2024-03-26T14:36:02","modified_gmt":"2024-03-26T14:36:02","slug":"viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/","title":{"rendered":"Viking Therapeutics&#8217; Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Promising Results Propel Shares Higher as VK2735 Shows Potential for Significant Weight Reduction<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Viking Therapeutics&#8217; (VKTX) latest achievement in weight loss research has sparked enthusiasm among investors, with its experimental tablet demonstrating significant efficacy in reducing weight. The company&#8217;s shares surged by 15% in premarket trading following the announcement.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In a small early-stage trial, participants administered with Viking&#8217;s drug VK2735 experienced weight loss of up to 3.3%, surpassing Wall Street expectations. The oral tablet offers a convenient alternative to existing under-the-skin injections, aligning with patient preferences for ease of administration.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">With plans to explore higher doses in subsequent trials and initiate mid-stage studies in obese patients later this year, Viking remains poised for further breakthroughs in weight management. The mild-to-moderate side effects reported indicate a promising safety profile, paving the way for continued development and potential commercialization.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Viking&#8217;s innovative approach to weight loss therapy, coupled with its commitment to addressing patient needs, underscores its position as a frontrunner in the biopharmaceutical industry. As the company progresses with its research, the prospect of offering effective oral treatments for obesity holds significant promise for patients seeking sustainable solutions to manage their weight.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Read original press release:<a href=\"https:\/\/www.prnewswire.com\/news-releases\/viking-therapeutics-announces-results-from-phase-1-clinical-trial-of-oral-tablet-formulation-of-dual-glp-1gip-receptor-agonist-vk2735-302098869.html\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">here<\/mark><\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/truth-social-djt-makes-striking-debut-on-nasdaq-surging-over-50\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Truth Social (DJT) Makes Striking Debut on Nasdaq, Surging Over 50%<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Promising Results Propel Shares Higher as VK2735 Shows Potential for Significant Weight Reduction Viking Therapeutics&#8217; (VKTX) latest achievement in weight loss research has sparked enthusiasm among investors, with its experimental tablet demonstrating significant efficacy in reducing weight. The company&#8217;s shares surged by 15% in premarket trading following the announcement. In a small early-stage trial, participants [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1422,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":{"subtitle":"","format":"standard","video":"","gallery":"","source_name":"","source_url":"","via_name":"","via_url":"","override_template":"0","override":[{"template":"8","single_blog_custom":"","parallax":"1","fullscreen":"1","layout":"right-sidebar-narrow","sidebar":"author","second_sidebar":"single-right","sticky_sidebar":"1","share_position":"top","share_float_style":"share-monocrhome","show_share_counter":"0","show_view_counter":"0","show_featured":"1","show_post_meta":"1","show_post_author":"1","show_post_author_image":"1","show_post_date":"1","post_date_format":"default","post_date_format_custom":"Y\/m\/d","show_post_category":"1","show_post_reading_time":"1","post_reading_time_wpm":"300","show_zoom_button":"0","zoom_button_out_step":"2","zoom_button_in_step":"3","show_post_tag":"1","show_prev_next_post":"1","show_popup_post":"1","number_popup_post":"1","show_author_box":"1","show_post_related":"1","show_inline_post_related":"0"}],"override_image_size":"0","image_override":[{"single_post_thumbnail_size":"crop-500","single_post_gallery_size":"crop-500"}],"trending_post":"0","trending_post_position":"meta","trending_post_label":"Trending","sponsored_post":"0","sponsored_post_label":"Sponsored by","sponsored_post_name":"","sponsored_post_url":"","sponsored_post_logo_enable":"0","sponsored_post_logo":"","sponsored_post_desc":"","disable_ad":"0"},"jnews_primary_category":{"id":"","hide":""},"jnews_social_meta":{"fb_title":"","fb_description":"","fb_image":"","twitter_title":"","twitter_description":"","twitter_image":""},"jnews_override_counter":{"override_view_counter":"0","view_counter_number":"0","override_share_counter":"0","share_counter_number":"0","override_like_counter":"0","like_counter_number":"0","override_dislike_counter":"0","dislike_counter_number":"0"},"jnews_post_split":{"enable_post_split":"0","post_split":[{"template":"1","tag":"h2","numbering":"asc","mode":"normal","first":"0","enable_toc":"0","toc_type":"normal"}]},"footnotes":""},"categories":[308,360],"tags":[],"coauthors":[453],"class_list":["post-1864","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-mid-cap"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Viking Therapeutics&#039; Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Viking Therapeutics&#039; Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Promising Results Propel Shares Higher as VK2735 Shows Potential for Significant Weight Reduction Viking Therapeutics&#8217; (VKTX) latest achievement in weight loss research has sparked enthusiasm among investors, with its experimental tablet demonstrating significant efficacy in reducing weight. The company&#8217;s shares surged by 15% in premarket trading following the announcement. In a small early-stage trial, participants [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-26T14:36:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-26T14:36:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Liliana Vida\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Liliana Vida\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/\"},\"author\":{\"name\":\"Liliana Vida\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\"},\"headline\":\"Viking Therapeutics&#8217; Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials\",\"datePublished\":\"2024-03-26T14:36:01+00:00\",\"dateModified\":\"2024-03-26T14:36:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/\"},\"wordCount\":222,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"articleSection\":[\"Biotechnology\",\"Mid-Cap\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/\",\"name\":\"Viking Therapeutics' Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"datePublished\":\"2024-03-26T14:36:01+00:00\",\"dateModified\":\"2024-03-26T14:36:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-mart-production-7088524-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"radiology-2\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2024\\\/03\\\/26\\\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Viking Therapeutics&#8217; Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/db8b371dfcaa698eaedb5afa5e713fb1\",\"name\":\"Liliana Vida\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g\",\"caption\":\"Liliana Vida\"},\"description\":\"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/stoxpo-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Viking Therapeutics' Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/","og_locale":"en_US","og_type":"article","og_title":"Viking Therapeutics' Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials - Stoxpo","og_description":"Promising Results Propel Shares Higher as VK2735 Shows Potential for Significant Weight Reduction Viking Therapeutics&#8217; (VKTX) latest achievement in weight loss research has sparked enthusiasm among investors, with its experimental tablet demonstrating significant efficacy in reducing weight. The company&#8217;s shares surged by 15% in premarket trading following the announcement. In a small early-stage trial, participants [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/","og_site_name":"Stoxpo","article_published_time":"2024-03-26T14:36:01+00:00","article_modified_time":"2024-03-26T14:36:02+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","type":"image\/jpeg"}],"author":"Liliana Vida","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Liliana Vida","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/"},"author":{"name":"Liliana Vida","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1"},"headline":"Viking Therapeutics&#8217; Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials","datePublished":"2024-03-26T14:36:01+00:00","dateModified":"2024-03-26T14:36:02+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/"},"wordCount":222,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","articleSection":["Biotechnology","Mid-Cap"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/","url":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/","name":"Viking Therapeutics' Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","datePublished":"2024-03-26T14:36:01+00:00","dateModified":"2024-03-26T14:36:02+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-mart-production-7088524-scaled.jpg","width":2560,"height":1707,"caption":"radiology-2"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2024\/03\/26\/viking-therapeutics-breakthrough-oral-tablet-spurs-excitement-in-weight-loss-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Viking Therapeutics&#8217; Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/db8b371dfcaa698eaedb5afa5e713fb1","name":"Liliana Vida","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=ga2a6b2037962b89d9d0225f04f06bac6","url":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68bef66f029f68660c9d513c7abee60cc2c1cc99a1c80c13e95592bed4296cfd?s=96&d=mm&r=g","caption":"Liliana Vida"},"description":"Liliana is a seasoned financial journalist with enthusiasm for unraveling the complexities of market fluctuations and identifying paradigm-shifting trends within the stock market landscape. With years of experience in covering the stock market and publicly traded companies, Liliana has honed her skills in turning press releases into concise, informative articles. For tips and inquiries, reach out to Liliana at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/stoxpo-com\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=1864"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1864\/revisions"}],"predecessor-version":[{"id":1865,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/1864\/revisions\/1865"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1422"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=1864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=1864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=1864"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=1864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}